{"id":"W1805832649","doi":"10.2165/00024669-200605040-00002","title":"Epidermal Growth Factor Receptor Antagonists in Pancreatic Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Erlotinib; Cetuximab; Pancreatic cancer; Gemcitabine; Medicine; Epidermal growth factor receptor; EGFR inhibitors; Oncology; Gefitinib; Erlotinib Hydrochloride; Internal medicine; Cancer; Pharmacology; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004805299,0.0002044736,0.0005455038,0.0002805933,0.0002078038,0.0004779149,0.0001714394,0.0003423661,0.001933409],"category_scores_gemma":[0.0002332958,0.0001100932,0.0003220863,0.0003542408,0.000142183,0.0002825718,0.0001731301,0.0009846508,0.0003754198],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004033129,"about_ca_system_score_gemma":0.0005263175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005054532,"about_ca_topic_score_gemma":0.001934767,"domain_scores_codex":[0.9999044,0.00003248003,0.00001201046,0.000007367303,0.00001768595,0.00002604608],"domain_scores_gemma":[0.9998823,0.00004084954,0.00002350992,0.000008168271,0.00001231266,0.00003281729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01757674,0.00185242,0.01470922,0.001306562,0.0004581128,0.002169271,0.0001270951,0.001621126,0.05865449,0.002995734,0.02513055,0.8733987],"study_design_scores_gemma":[0.01390176,0.04379402,0.1188319,0.0006903869,0.001906961,0.02323643,0.0006040199,0.00263926,0.08475063,0.003342429,0.7062131,0.00008908257],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.494201,0.4688191,0.000828669,0.00745448,0.0009629024,0.00008068058,0.0004012795,0.0001583015,0.02709349],"genre_scores_gemma":[0.7604947,0.2252933,0.0009004759,0.001794592,0.0005704612,0.00007970318,0.0005998663,0.00002053444,0.01024644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001933409,"threshold_uncertainty_score":0.006467879,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0199594079136214,"score_gpt":0.3601543889147901,"score_spread":0.3401949810011687,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}